Emergent BioSolutions (EBS) Finished Goods (2011 - 2018)

Emergent BioSolutions' Finished Goods history runs 8 years deep, the most recent figure standing at $50.8 million for Q4 2018.

• In Q4 2018, Finished Goods rose 68.77% year-over-year to $50.8 million; the TTM figure through Dec 2018 stood at $50.8 million (up 68.77% YoY), while the FY2018 annual figure was $50.8 million, up 68.77% from the prior year.
• Finished Goods was $50.8 million for Q4 2018 at Emergent BioSolutions, up from $27.1 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $50.8 million in Q4 2018 to a low of $6.9 million in Q4 2015.
• Historically, Finished Goods has averaged $23.0 million across 5 years, with a median of $23.9 million in 2015.
• The sharpest annual moves came in 2014 and 2017: Finished Goods jumped 669.76% in 2014, then plunged 58.88% in 2017.
• A 5-year view of Finished Goods shows it stood at $14.8 million in 2014, then plunged by 53.43% to $6.9 million in 2015, then jumped by 240.34% to $23.5 million in 2016, then rose by 28.12% to $30.1 million in 2017, then soared by 68.77% to $50.8 million in 2018.
• The last three Finished Goods figures came in at $50.8 million (Q4 2018), $27.1 million (Q3 2018), and $25.4 million (Q2 2018), per Business Quant data.